Low incidence of retinopathy during peginterferon alpha-2b and lamivudine therapy for chronic hepatitis B

J Hepatol. 2006 Jul;45(1):160-1; author reply 161-2. doi: 10.1016/j.jhep.2006.04.003. Epub 2006 Apr 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / adverse effects*
  • Evoked Potentials, Visual / drug effects
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Incidence
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Lamivudine / adverse effects*
  • Lamivudine / therapeutic use
  • Polyethylene Glycols
  • Recombinant Proteins
  • Retinal Diseases / chemically induced*
  • Retinal Diseases / epidemiology
  • Retinal Diseases / physiopathology
  • Risk Factors

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Lamivudine
  • Polyethylene Glycols
  • peginterferon alfa-2b